Advances in transcutaneous vaccine delivery: do all ways lead to Rome?
about
Microneedle Coating Techniques for Transdermal Drug DeliveryMicroneedle-based drug and vaccine delivery via nanoporous microneedle arraysEffect of microneedle treatment on the skin permeation of a nanoencapsulated dyeEfficacy of imiquimod-based transcutaneous immunization using a nano-dispersed emulsion gel formulationFacilitation of transcutaneous drug delivery and vaccine immunization by a safe laser technology.Generation of more effective cancer vaccinesTranscutaneous vaccination via laser microporation.Transcutaneous immunotherapy via laser-generated micropores efficiently alleviates allergic asthma in Phl p 5-sensitized mice.Transcutaneous immunization system using a hydrotropic formulation induces a potent antigen-specific antibody response.Transcutaneous delivery of CpG-adjuvanted allergen via laser-generated micropores.Laser microporation of the skin: prospects for painless application of protective and therapeutic vaccines.Laser-engineered dissolving microneedle arrays for protein delivery: potential for enhanced intradermal vaccination.Effective transcutaneous immunization by antigen-loaded flexible liposome in vivo.Local response to microneedle-based influenza immunization in the skin.Potential of nanoparticles for allergen-specific immunotherapy - use of silica nanoparticles as vaccination platform.Determinants of efficacy and safety in epicutaneous allergen immunotherapy: summary of three clinical trials.New routes for allergen immunotherapy.Gua Sha, a press-stroke treatment of the skin, boosts the immune response to intradermal vaccination.A combined approach of hollow microneedles and nanocarriers for skin immunization with plasmid DNA encoding ovalbumin.Epicutaneous allergen administration: is this the future of allergen-specific immunotherapy?Charged liposomes as carriers to enhance the permeation through the skin.Microneedle-mediated vaccine delivery: harnessing cutaneous immunobiology to improve efficacy.Adjuvants for human vaccines.Nanocarrier-based topical drug delivery for the treatment of skin diseases.Delivery of antigens used for vaccination: recent advances and challenges.Transdermal immunization: biological framework and translational perspectives.New directions in immunotherapy.Transcutaneous antigen delivery system.Skin permeabilization for transdermal drug delivery: recent advances and future prospects.Advanced materials and nanotechnology for drug delivery.Not just for tumor targeting: unmet medical needs and opportunities for nanomedicine.Solid-in-oil nanodispersions for transdermal drug delivery systems.Development of a microparticulate prostate cancer vaccine and evaluating the effect of route of administration on its efficacy via the skin.New Horizons in the Development of Novel Needle-Free Immunization Strategies to Increase Vaccination Efficacy.Dissolving Microneedle Patches for Dermal VaccinationAlternative vaccine administration by powder injection: Needle-free dermal delivery of the glycoconjugate meningococcal group Y vaccineTranscutaneous immunization as preventative and therapeutic regimens to protect against experimental otitis media due to nontypeable Haemophilus influenzae.Novel hollow microneedle technology for depth-controlled microinjection-mediated dermal vaccination: a study with polio vaccine in rats.Effective transcutaneous immunization against hepatitis B virus by a combined approach of hydrogel patch formulation and microneedle arrays.Epicutaneous Immunotherapy for Aeroallergen and Food Allergy.
P2860
Q26778139-FE5ADF7B-EFB3-49A1-9F00-9CE98D21BB5CQ28085656-834EECBF-317A-4D78-91B2-38C83F807570Q28391616-21E2F357-285B-4276-9C47-DADA6EDB5899Q28540777-B0432083-D52B-4A47-93B5-3995E853C64DQ34133549-BA89B95D-08B5-4118-A544-571319AAB028Q34169981-F6CBF4BB-1442-458A-8D44-80EEB01CECF9Q34323166-2EAAECF9-9F42-42CC-A159-7FF433E7EA03Q34402672-B12960F8-7976-4317-AEA4-105DBEBE6D60Q34460808-2C6F176B-8D12-4EDF-8D44-70A5ED34D4CCQ34527154-C9075DA7-DC0C-4437-843F-209E6EE77934Q34593082-1396777C-379D-47EC-AD4E-762CDEFB8087Q35132732-83B89743-3193-48EE-A457-5AC78408D32CQ35656890-2B88C683-6A56-4757-9FB9-1DC587F784E3Q35826992-2941D57E-CE07-4F6B-B786-17A8573DCCE7Q36056484-394F629F-95C0-4471-8409-23AE05CCD63AQ36302500-2340C65E-06D2-42A2-8493-3B7309D67841Q36864957-83342EDF-78F1-4E88-9468-CC6593240D0BQ37267223-A5CEFD2D-521B-46FC-8493-C9F8F12C7C3DQ37623985-11E5D61A-AD80-4066-8A1B-50A8A0A5020AQ37868794-E4159F44-4C76-4D00-A3AD-935AD343EBFBQ37873946-B96C42F9-5566-46F5-A9EA-B3C17565C495Q37999873-7D8E701C-5FDE-4721-BF3C-16BF1ACEBA4BQ38004229-1FD28F0B-7151-4097-8332-721795760EC5Q38007558-6D24CA38-3216-4F0E-A903-FC560A76417DQ38028969-7889EC42-63D6-4F56-A531-BFE7EB427B7CQ38068975-28414224-55C0-471B-ADE9-E939A2467364Q38073718-A58794BD-8DD8-49FA-9CF8-00775B0B9614Q38076804-AABAEB31-4E84-42D0-A958-9682119492ADQ38176047-FADD95B2-EE3D-42CC-B10D-91AA71ABF2D4Q38180643-399D45BE-F33A-48E2-B289-C77247503FF2Q38602136-87EA6407-DE98-4656-BDFD-D9DC41505D76Q38830870-6895B664-7C3C-459A-B461-368E60B9B4D6Q38873574-292C3401-2871-46D5-AEA6-AE2D455BF989Q38883770-2B7CB804-CE0C-41E5-A49F-9F6F37746D54Q39440948-2103736B-0548-410A-8697-8C5A7BA0E693Q41512011-2C8675AB-D1AA-430A-817D-0027DA36FA32Q42061615-D523D019-DEC9-47C2-B336-FB1A8E0B48F9Q42240678-293A6B05-7E0F-4CA7-9CB8-78BD0995BC27Q42280914-7DB34259-8942-4B9B-9D9D-E621D24833A2Q42578489-A2250CE0-F4E5-4BA2-9A9C-E6BE0BAE0B40
P2860
Advances in transcutaneous vaccine delivery: do all ways lead to Rome?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 September 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Advances in transcutaneous vaccine delivery: do all ways lead to Rome?
@en
Advances in transcutaneous vaccine delivery: do all ways lead to Rome?
@nl
type
label
Advances in transcutaneous vaccine delivery: do all ways lead to Rome?
@en
Advances in transcutaneous vaccine delivery: do all ways lead to Rome?
@nl
prefLabel
Advances in transcutaneous vaccine delivery: do all ways lead to Rome?
@en
Advances in transcutaneous vaccine delivery: do all ways lead to Rome?
@nl
P2093
P1476
Advances in transcutaneous vaccine delivery: do all ways lead to Rome?
@en
P2093
Elly van Riet
Joke A Bouwstra
Suzanne M Bal
Wim Jiskoot
P304
P356
10.1016/J.JCONREL.2010.09.018
P407
P577
2010-09-24T00:00:00Z